KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMY) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to $2.2 billion.

  • Bristol Myers Squibb's Net Income towards Common Stockholders rose 8971.48% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 billion, marking a year-over-year increase of 18215.79%. This contributed to the annual value of -$8.9 billion for FY2024, which is 21110.7% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Net Income towards Common Stockholders of $2.2 billion as of Q3 2025, which was up 8971.48% from $1.3 billion recorded in Q2 2025.
  • Over the past 5 years, Bristol Myers Squibb's Net Income towards Common Stockholders peaked at $2.5 billion during Q1 2025, and registered a low of -$11.9 billion during Q1 2024.
  • In the last 5 years, Bristol Myers Squibb's Net Income towards Common Stockholders had a median value of $1.6 billion in 2024 and averaged $953.6 million.
  • Per our database at Business Quant, Bristol Myers Squibb's Net Income towards Common Stockholders skyrocketed by 78150.68% in 2021 and then plummeted by 62527.57% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Net Income towards Common Stockholders stood at $2.4 billion in 2021, then decreased by 14.63% to $2.0 billion in 2022, then dropped by 12.99% to $1.8 billion in 2023, then plummeted by 95.69% to $76.0 million in 2024, then skyrocketed by 2788.16% to $2.2 billion in 2025.
  • Its Net Income towards Common Stockholders was $2.2 billion in Q3 2025, compared to $1.3 billion in Q2 2025 and $2.5 billion in Q1 2025.